Earnings Feed
Start Free
|4Oct 29, 6:13 PM ET

ALLERGAN INC 4

4 · ALLERGAN INC · Filed Oct 29, 2003

Insider Transaction Report

Form 4
Period: 2003-10-28
ALLERGAN INC(AGN)
FELLOWS DAVID A
CVP, Pres., EuroAsia/Africa/ME
Transactions
  • Sale

    Common Stock

    2003-10-28$76.06/sh−20,000$1,521,240→ 8,986.41 total
  • Exercise/Conversion

    Common Stock

    2003-10-28$13.01/sh+20,000$260,120→ 28,986.41 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2003-10-28$70.06/sh−20,000$1,401,240→ 21,520 total
    Exercise: $13.01Exp: 2007-04-22→ Common Stock (20,000 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    6,332.405

  • Common Stock

    (indirect: By Spouse)
    2,314.775

  • Common Stock

    (indirect: By Trust)
    3,497.71
Footnotes (2)
  • [F1]Includes shares acquired under the Allergan, Inc. Dividend Reinvestment Plan.
  • [F2]Nonqualified stock option granted 4/22/97 under the issuer's incentive compensation plan, which option vested ratably over 4 years from the date of grant.

Documents

1 file
  • 4
    fel217.xmlPrimary